Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Ind-Swift Laboratories Ltd. ( (IN:INDSWFTLAB) ) is now available.
Ind-Swift Laboratories Ltd. has announced the scheduling of its 30th Annual General Meeting (AGM) on September 29, 2025, which will be conducted via video conferencing in compliance with regulatory guidelines. The company has also made its Annual Report for the financial year 2024-25 available online, ensuring transparency and accessibility for stakeholders. This move highlights Ind-Swift’s commitment to maintaining open communication with its shareholders and adhering to regulatory requirements, potentially strengthening its position in the market.
More about Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and intermediates. The company is known for its commitment to quality and innovation, serving a global market with a diverse range of pharmaceutical products.
Average Trading Volume: 18,511
Technical Sentiment Signal: Buy
Current Market Cap: 6.18B INR
For a thorough assessment of INDSWFTLAB stock, go to TipRanks’ Stock Analysis page.